• RN Home
  • About RocketNews
    • About RocketNews
    • Article Submission Form
    • Commercial News Posting and Writing Services
    • Contact RocketNews
  • News Categories
    • Business
    • Climate Change
    • Education
    • Energy
    • Entertainment
    • Financial
    • Health
    • Jobs
    • Politics
    • Religion
    • Science
    • Sports
    • Stock Market News
    • Technology
    • Top Stories
    • Travel
    • World

Nike expects more falling sales, as stock sinks amid worries turnaround is not working

by News Feed Editor | Mar 31, 2026 | Stock Market

Nike reported quarterly results that were a bit better than Wall Street’s expectations, but investors still didn’t appear convinced of the sneaker giant’s turnaround efforts. Article Attribution | Read More at Article Source

20 stocks that bucked the stock market’s decline in March with gains of up to 40%

by News Feed Editor | Mar 31, 2026 | Stock Market

Energy stocks have fared well as crude-oil prices have shot up, but one other industry group has also done well since the U.S. and Israel attacked Iran on Feb. 28. Article Attribution | Read More at Article Source

My wife and I buy promotional CDs with our tax-refund check. Is now a bad time to switch to Treasurys?

by News Feed Editor | Mar 31, 2026 | Stock Market

“We have no experience with Treasurys .” Article Attribution | Read More at Article Source

These 20 stocks in the S&P 500 fell hardest during March

by News Feed Editor | Mar 31, 2026 | Stock Market

The worst performers included cosmetics companies, cruise operators, airlines and Paramount Skydance, which was down 33% for the month Article Attribution | Read More at Article Source

Here are 12 top tech-themed stock picks from UBS analysts

by News Feed Editor | Mar 31, 2026 | Stock Market

The investment bank has “high conviction” in Amazon’s growth potential — with AWS estimates that are far above what investors may be expecting. Article Attribution | Read More at Article Source

With Zepbound approved for sleep apnea, Lilly spends up to $7.8 billion for a company with a narcolepsy drug

by News Feed Editor | Mar 31, 2026 | Stock Market

The company, which is flush with cash from sales of its market-leading GLP-1 franchise, has been an active dealmaker. Article Attribution | Read More at Article Source
« Older Entries
Next Entries »

Recent Posts

  • The first American autonomous ground vehicles are fighting in Ukraine
  • Energy Major Shell Cashes In On Volatile Oil Markets – Bloomberg.com
  • Energy Major Shell Cashes In On Volatile Oil Markets – Bloomberg.com
  • Trump admin could undermine energy efficiency with dubious new analysis – Yahoo
  • Trump admin could undermine energy efficiency with dubious new analysis – Yahoo

Recent Comments

No comments to show.

About RN

Rocketnews is an aggregator of the top online news articles and stories from around the globe. Rocketnews uses news feeds from a variety on online news feed providers including Feedzilla, Yahoo, and the BBC. Addition news feed providers included online media suppliers, local and regional publications, industry journals, companies, governments, universities, PR companies, official organizations, associations, shopping guides and weblogs. Featured content providers include Reuters, Metacafe, News Corporation, About, BBC and The Sun.

Website Awards

2004 Webby Award Nomination

RocketNews nominated for a Webby Award

Search Engine Watch past honorable mention winner for Best News Search Engine.

More Info

About RocketNews

Contact RocketNews

COVID-19 Dashboard

Definitions and Terms

Privacy Policy

Site Design and Operation by Murray Owen LLC | A Web Development and Operations Company